Bioventix is a biotechnology company specialising in the development of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics and drugs of abuse testing.The high-affinity antibodies created at Bioventix have advantages over conventional rodent monoclonal antibodies where the target is present at low concentration, or where the target is a hapten or small molecule. The use of high-affinity SMAs also confers improved assay sensitivity and precision. Bioventix is traded in the ISDX Exchange HERE